To understand AOD-9604, it helps to understand growth hormone first
Retatrutide has the potential to enhance weight reduction outcomes and manage obesity-related comorbidities like diabetes and hypertension (high blood pressure) when paired with a healthy diet, consistent exercise, and lifestyle adjustments
As researchers learn more about its potential to extend lifespan, boost immunity, improve strength and physical performance, and ward off age-related illnesses, more people are supplementing with glutathionewhich is generally very safe
The FDA similarly removed it from its shortage list on February 21, 2025, but this time, it designated off-ramps for production of compounded types right off the bat: Technically, 503A pharmacies have until April 22 to quit making semaglutide drugs, while 503B facilities have until May 22
It is provided strictly for scientific research use only
The first impact they saw was that these medications helped people with type 2 diabetes reduce their glucose levels GLP-1 helps put away extra glucose and that was the primary use